Bepotastine besilate
| Title | Journal |
|---|---|
| Health-related quality of life assessed by the effect of bepotastine besilate in patients with pruritus: importance of emotions score in atopic dermatitis. | The Journal of dermatology 20120601 |
| Effects of bepotastine and fexofenadine on histamine-induced flare, wheal and itch. | International archives of allergy and immunology 20120101 |
| Next-day residual sedative effect after nighttime administration of an over-the-counter antihistamine sleep aid, diphenhydramine, measured by positron emission tomography. | Journal of clinical psychopharmacology 20101201 |
| Non-clinical pharmacology, pharmacokinetics, and safety findings for the antihistamine bepotastine besilate. | Current medical research and opinion 20101001 |
| Oral bepotastine: in allergic disorders. | Drugs 20100820 |
| Bepotastine besilate, a highly selective histamine H(1) receptor antagonist, suppresses vascular hyperpermeability and eosinophil recruitment in in vitro and in vivo experimental allergic conjunctivitis models. | Experimental eye research 20100701 |
| Bepotastine besilate ophthalmic solution for the relief of nonocular symptoms provoked by conjunctival allergen challenge. | Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 20100701 |
| Bepotastine (bepreve)--an ophthalmic H1-antihistamine. | The Medical letter on drugs and therapeutics 20100208 |
| New drugs: asenapine, iloperidone, and bepotastine besilate. | Journal of the American Pharmacists Association : JAPhA 20100101 |
| Multiple H1-antihistamine-induced urticaria. | The Journal of dermatology 20090401 |
| Bepotastine besilate OD tablets suppress nasal symptoms caused by Japanese cedar pollen exposure in an artificial exposure chamber (OHIO Chamber). | Expert opinion on pharmacotherapy 20090301 |
| Downmodulatory effects of the antihistaminic drug bepotastine on cytokine/chemokine production and CD54 expression in human keratinocytes. | Skin pharmacology and physiology 20090101 |
| Brain histamine H1 receptor occupancy of orally administered antihistamines, bepotastine and diphenhydramine, measured by PET with 11C-doxepin. | British journal of clinical pharmacology 20080601 |
| Analysis of disease-dependent sedative profiles of H(1)-antihistamines by large-scale surveillance using the visual analog scale. | Methods and findings in experimental and clinical pharmacology 20080401 |
| Oral administration of bepotastine besilate suppressed scratching behavior of atopic dermatitis model NC/Nga mice. | International archives of allergy and immunology 20080101 |
| Involvement of histamine released from mast cells in acute radiation dermatitis in mice. | Journal of pharmacological sciences 20070601 |
| Suppression by bepotastine besilate of substance P-induced itch-associated responses through the inhibition of the leukotriene B4 action in mice. | European journal of pharmacology 20061010 |
| Effect of P-glycoprotein on intestinal absorption and brain penetration of antiallergic agent bepotastine besilate. | Drug metabolism and disposition: the biological fate of chemicals 20060501 |